The mechanisms of alloxan- and streptozotocin-induced diabetes

2007/12/17 by S. Lenzen, Sigurd Lenzen · 30 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Pancreatic function and diabetes #Diet, Metabolism, and Disease #Metabolism, Diabetes, and Cancer

paper · pdf · doi:10.1007/s00125-007-0886-7

Cited by

• Human fetal pancreatic insulin-producing cells proliferate in vitro
• Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models
• Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes
• Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development
• Long-term culture of human pancreatic islets reveals reduced metal ion pathways in their gene signature
• Mouse Models for Type 1 Diabetes. [europepmc]
• The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. [europepmc]
• O-GlcNAc signaling in the cardiovascular system. [europepmc]
• Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. [europepmc]
• Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. [europepmc]
• Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. [europepmc]
• Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice. [europepmc]
• The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease. [europepmc]
• Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression. [europepmc]
• Models and mechanisms for hippocampal dysfunction in obesity and diabetes. [europepmc]
• High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. [europepmc]
• Experimental Diabetes Mellitus in Different Animal Models. [europepmc]
• Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes. [europepmc]
• The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production. [europepmc]
• Microglia in Retinal Degeneration. [europepmc]
• ASK1 inhibition: a therapeutic strategy with multi-system benefits. [europepmc]
• Lutein Supplementation for Eye Diseases. [europepmc]
• Antidiabetic Potency, Antioxidant Effects, and Mode of Actions of Citrus reticulata Fruit Peel Hydroethanolic Extract, Hesperidin, and Quercetin in Nicotinamide/Streptozotocin-Induced Wistar Diabetic Rats. [europepmc]
• Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. [europepmc]
• Diabetic fibrosis. [europepmc]
• Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice. [europepmc]
• Experimental animal models for diabetes and its related complications-a review. [europepmc]
• Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System. [europepmc]
• Streptozotocin as a tool for induction of rat models of diabetes: a practical guide. [europepmc]
• Delineating mouse β-cell identity during lifetime and in diabetes with a single cell atlas. [europepmc]